Form 4 for RPRX Royalty Pharma plc
Accepted 2026-05-15 16:37:04 ET · period of report 2026-05-14 · accession 0001405104-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-15 16:37 | 2026-05-14 | RPRX | Norden Gregory | Dir | S - Sale | $53.00 | -3,045 | 191.8K | -2% | -$161.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2026-05-14 | S | D | 3,045 | $53.00 | 191,803 | D | — | — | (F1) The reported transaction was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on February 12, 2026. |